These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8199043)

  • 1. Domiciliary desensitization therapy for young boys with haemophilia and factor VIII inhibitors.
    Lilleyman JS
    Br J Haematol; 1994 Feb; 86(2):433-5. PubMed ID: 8199043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is oral tolerance therapy possible for haemophilia with inhibitors?
    Terada K; Yagi Y; Niizuma T; Kataoka N
    Vox Sang; 2001 Jan; 80(1):61-2. PubMed ID: 11339071
    [No Abstract]   [Full Text] [Related]  

  • 3. A continuing challenge: treatment of hemophilic children with acquired factor VIII inhibitors.
    Bell BA
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):105-6. PubMed ID: 8447549
    [No Abstract]   [Full Text] [Related]  

  • 4. Central venous access catheters in children with haemophilia.
    Blanchette VS; al-Musa A; Stain AM; Filler RM; Ingram J
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S39-44. PubMed ID: 8735796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
    Collins PW; Chalmers E; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Hay CR;
    Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
    [No Abstract]   [Full Text] [Related]  

  • 6. How will immune tolerance protocols affect self-sufficiency goals?
    Brackmann HH
    Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S77-9. PubMed ID: 7795144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia.
    Ljung R; Petrini P; Lindgren AK; Berntorp E
    Acta Paediatr; 1992 Nov; 81(11):918-20. PubMed ID: 1467614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does peroral administration of factor VIII induce oral tolerance in patients with acquired haemophilia A?
    Lindgren A; Wadenvik H; Tarkowski A; Tengborn L
    Thromb Haemost; 2000 Apr; 83(4):632-3. PubMed ID: 10780332
    [No Abstract]   [Full Text] [Related]  

  • 9. The incidence of inhibitors in hemophilia A and the induction of immune tolerance.
    Briët E; Peters M
    Adv Exp Med Biol; 2001; 489():89-97. PubMed ID: 11554594
    [No Abstract]   [Full Text] [Related]  

  • 10. Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.
    Gilles JG; Desqueper B; Lenk H; Vermylen J; Saint-Remy JM
    J Clin Invest; 1996 Mar; 97(6):1382-8. PubMed ID: 8617869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization to factor VIII in a patient with classic hemophilia and C2 deficiency.
    Jamieson DM; Stafford CT; Maloney MJ; Lutcher CL
    Ann Allergy; 1987 Mar; 58(3):215-20. PubMed ID: 3103496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors in nonsevere haemophilia A: outcome and eradication strategies.
    van Velzen AS; Eckhardt CL; Hart DP; Peters M; Rangarajan S; Mancuso ME; Smiers FJ; Khair K; Petrini P; Jiménez-Yuste V; Hay CR; van der Bom JG; Yee TT; Fijnvandraat K;
    Thromb Haemost; 2015 Jul; 114(1):46-55. PubMed ID: 25879247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central venous catheter-associated thrombosis in severe haemophilia.
    Vidler V; Richards M; Vora A
    Br J Haematol; 1999 Mar; 104(3):461-4. PubMed ID: 10086779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The young hemophiliac, inhibitors and immune tolerance].
    Rothschild C
    Transfus Clin Biol; 1999 Jun; 6(3):191-4. PubMed ID: 10422212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of the Port-A-Cath in children with haemophilia--a review.
    Van Den Berg HM; Fischer K; Roosendaal G; Mauser-Bunschoten EP
    Haemophilia; 1998 Jul; 4(4):418-20. PubMed ID: 9873764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM; van Helden PM; Schwarz HP; Hausl C
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of Factor VIII Inhibitor Titers During Immune Tolerance Induction With Recombinant Factor VIII-Fc Fusion Protein.
    Groomes CL; Gianferante DM; Crouch GD; Parekh DS; Scott DW; Lieuw K
    Pediatr Blood Cancer; 2016 May; 63(5):922-4. PubMed ID: 26739399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response against serial infusion of factor VIII antigen through an implantable venous-access device system in haemophilia A mice.
    Madoiwa S; Kobayashi E; Kashiwakura Y; Sakata A; Yasumoto A; Ohmori T; Mimuro J; Sakata Y
    Haemophilia; 2012 May; 18(3):e323-30. PubMed ID: 22044430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors in haemophilia: clinical aspects.
    Dimichele D; Rivard G; Hay C; Antunes S
    Haemophilia; 2004 Oct; 10 Suppl 4():140-5. PubMed ID: 15479387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary report of the First International Conference on inhibitors in haemophilia A.
    Lacroix-Desmazes S; Scott DW; Goudemand J; Van Den Berg M; Makris M; Van Velzen AS; Santagostino E; Lillicrap D; Rosendaal FR; Hilger A; Sauna ZE; Oldenburg J; Mantovani L; Mancuso ME; Kessler C; Hay CRM; Knoebl P; Di Minno G; Hoots K; Bok A; Brooker M; Buoso E; Mannucci PM; Peyvandi F
    Blood Transfus; 2017 Oct; 15(6):568-576. PubMed ID: 27893354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.